Introduction
The sessile growth of bacteria as biofilms causes serious problems in medical practice. Biofilms developed in clinical environments can be a source of nosocomial infections. They can also contaminate indwelling medical devices and cause both device malfunctions and infection complications of the patient.
In urinary-tract infections (UTI), E. coli are among the most frequent causative agents. Together with other virulence factors, their biofilm-forming capacity is of special importance for longer-term persistence and recurrence [1] , as well as for catheter-associated infections [2] [3] [4] [5] . Biofilm microorganisms are much more resistant to antibiotic treatments than plankton [3, 6, 7] . The problems caused by sessile bacteria require alternative approaches to biofilm control.
Natural biofilms are complicated consortia of species and strains. Interactions between them vary from synergism to antagonism [5, [8] [9] [10] . Antagonistic relations have been studied by many authors. The potential of commensal probiotic bacteria to interfere with the ability of pathogens in colonizing the host has been explored with the aim to develop alternative approaches for supportive medical applications. One very important group in focus is lactobacilli. A variety of Lactobacillus strains were reported as producers of inhibitory substances against other bacterial species, including pathogens [2, [11] [12] [13] . Released antibacterial substances in cell-free culture supernatants (CFS) can inhibit both the growth of different pathotypes of E. coli [14] [15] [16] and the expression of virulence factors [17] . In spite of the observation that in mixed biofilms lactobacilli can influence biofilm growth of other microorganisms or displace them from already formed biofilms [13, [18] [19] [20] , the effects of secreted Lactobacillus metabolites on biofilm formation have only rarely been addressed [20, 21] .
This study is focused on the possibility that released lactobacillus products could interfere with biofilm formation of E. coli laboratory and UTI strains on abiotic surfaces. As a source of CFS, 11 Lactobacillus vaginal and dairy-product isolates from the laboratory collection of the Institute of Microbiology were selected on the basis of their recently reported broad-spectrum antibacterial activities [22] [23] [24] . We collected evidence suggesting that highly diluted noninhibitory amounts of CFS (10 -2 to 10 -4 ) can still have a biofilm-modulation capacity and that this is probably due to factors different from those involved in their antibacterial activity.
Experimental Procedures

Microorganisms, growth media and preparation of CFS
The microbial cultures used in this study are listed in Table 1 . The E. coli strains were selected based on previous tests on biofilm formation [25] . They were kept frozen at -20°C in TSB (Difco) containing 20% glycerol.
Before the experiments, the strains were streaked on TS agar. Three single colonies were selected, inoculated separately in TSB and subcultivated twice in TSB at 37°C. From each of these, samples were applied on slant agar and used as a source of inocula.
The Lactobacillus strains were isolated from vaginal samples of healthy volunteer women or from dairy products ( Table 1) . They are a part of laboratory collection and were identified to the species level in our previous work [22, 26] Escherichia coli PU-3 Urine, woman with pyelonephritis, BM-PU [42] Escherichia coli PU-13 Am-r, Sxt-r Urine, man with cystitis, BM-PU [42] Lactobacillus strains:
Lactobacillus gasseri Lb821 (LB1) 
Effects of 10 -2 diluted CFS on E. coli planktonic growth
To avoid interference of antibacterial and antibiofilm activities of the CFS, non-inhibitory dilutions of the CFS were applied throughout this study. These were determined by an initial disk-diffusion assay. E. coli were plated on Müller-Hinton agar. Disks (5 mm) were applied onto the plates and loaded with 10 μl of the LB filtrates -non-diluted, or decimally diluted in M63 medium. Inhibition was estimated after 24 h of growth at 37°C. Antibacterial activities of the 11 Lactobacillus spent cultures were confirmed for non-diluted and diluted 10 -1 CFS. These varied from strongly bactericidal to low bacteriostatic activity. No inhibition was registered with higher-order dilutions, 10 -2 , 10 -3 , and 10 -4 which were further used in biofilm tests.
The influence of the 10 -2 diluted CFS on planktonic growth was checked in M63 medium. The E. coli strains were cultivated overnight at 37°C in TSB and diluted 1:100 in M63 medium supplemented with 10 -2 of either MRS (control) or CFS. Samples of 150 μl were placed in 96-well U-shaped microtitre plates (Nunc). Each variant was repeated in 6 wells. The samples were incubated at 37°C and turbidity was measured hourly by a LP 400 ELISA reader at 620 nm.
Hydrophobicity
The E. coli strains were cultivated for 18 hours in M63 medium supplemented with 10 -2 of MRS (control) or LB1, LB5 and LB10. The bacteria were pelleted and resuspended in PBS to OD 620 1.0. The hydrophobicity test using hexadecane was applied as described by Li and McLandsborough [29] . Each bacterial suspension was divided into 1-ml samples that were placed into 6 separate tubes. Two of them were used to estimate OD of the whole culture, and 250 μl of hexadecane was added to the other 4 tubes. The samples were vortexed and left for 30 min at 37°C for the phases to separate. Two 250 μl aliquots of each of the hexadecane-untreated tubes, or from the water phases of the tubes with hexadecane, were placed in the wells of a 96-well plate and OD 620 was measured. The percentage of hydrophobic cells in each sample was calculated according to the formula A o -A hex /A o x100 where A o is the absorbance of the sample without hexadecane, and A hex is the absorbance of the sample with hexadecane.
Motility
Motility of the strains was estimated in 0.3% agar prepared in M63 medium supplemented with 10 -2 of either MRS (control) or LB1, LB5 and LB10. Overnight E. coli cultures were needle-inoculated into the agar. Motility halos were measured after 7 hours incubation at 22°C. Each variant was repeated in triplicate.
Biofilm growth estimation by crystal violet (CV) assay
The CV test was applied following the test medium and protocol described for UPEC biofilms [1] . In this series of studies, M63 medium supplemented with 10 -2 MRS (control) or 10 -2 , 10 -3 , and 10 -4 of the CFS was used. The E. coli were pre-cultivated similarly as in the test for planktonic growth and diluted 1:100 in the media. Samples of 100 μl were placed in 96-well U-shaped microtitre plates (Nunc). Six wells per variant were included in the plates and peripheral wells were avoided. Each plate contained one control row of 6 wells. Biofilm developed for 24 h at 22°C. Plankton was removed, the wells were washed with 0.85% NaCl and the biofilm was stained for 15 min with 0.1% crystal violet (CV). The dye was solubilised with 75% ethanol and the absorbance was measured at 550 nm. For each of the E. coli strains, samples from three single colonies were processed in parallel on three separate plates, each applied in 6 wells per variant.
Bacterial vitality in biofilms estimation by Live/Dead fluorescent test
Biofilms were statically cultivated for 24 h on microscope cover glasses spin-coated with methyl methacrylate. The glasses were placed in 6 cm glass Petri dishes and sterilized for 4 h at 180°C. Overnight E. coli cultures were dissolved 1:100 in M63 supplemented with 10 -2 of either MRS (control) or CFS from LB1, LB5 or LB10, and 3 ml of the bacteria suspension was carefully applied over the cover glasses. Following 24 h of cultivation at 22°C, plankton was removed and the glasses were delicately rinsed with 0.85% NaCl. The biofilms were colored by L13152 Live/Dead BacLight bacterial viability kit (Molecular Probes) using the protocol recommended by the provider. Observations were made on laser scanning microscope Nikon Eclipse Ti-U.
Proteinase K treatment of CFS
CFS samples from LB1, LB5 and LB10 were incubated for 1 hour at 37°C in the presence of 10 μg/ml of proteinase K (Boehringer Ingelheim) and the enzyme was inactivated for 10 min at 70°C. CV test was performed on biofilms grown in M63 alone (control) or supplemented with 10 -2 of untreated or proteinase K-treated CFS.
Preparation and application of samples from released exopolysaccharides (rPS)
Two ml quota of the CFS were extensively dialyzed overnight against dH 2 O and checked for rPS concentrations by the phenol-sulfuric acid method using a glucose standard. rPS was isolated from 10 ml of CFS of LB1, LB5 and LB10 by cold ethanol precipitation. The samples were dialysed and the amount of rPS was estimated as abovE. M63 medium was supplemented with 10 μg/ml of each rPS and the effects on biofilm growth were checked.
Statistical analysis
Calculation of mean values and standard deviations were done using Microsoft Excell. Comparisons of the mean values and estimation of differences between test and control samples were conducted via Student testing by the 'Statistika' software package (http://sites.google.com/site/borjanaboeva). In comparing different samples, probability values for P<0.05 were accepted as indicative for statistically significant differences.
Results
Effects of Lactobacillus cell-free supernatants on E. coli growth
To check for the possible interference of CFS with E. coli growth dynamics under the nutrient conditions applied further to biofilm growth, turbidity of samples inoculated in M63 medium with or without supplements was measured hourly. Most of the CFS had no notable effect on bacterial growth curves. As an exception, LB6 and LB7 suppressed growth during early stages of culture -hours 2 to 6, resulting in prolonged lag phase of E. coli cultures (Figure 1 ).
Modulation of E. coli biofilm growth by noninhibitory amounts of the Lactobacillus cell-free supernatants
The six E. coli strains differed in their biofilm-forming capacity. Strain E. coli 420 produced much higher amounts of biofilm (A 550 0.820±0.092) than the other strains. It was followed by E. coli W1655 (A 550 0.275±0.087), and then the other strains for which A 550 was within the range between 0.150 and 0.100. The biofilm-modulating effects of the CFS were registered at three decimal dilutions (10 -2 , 10 -3 and 10 -4 ). For easier comparison of CFS effects between the E. coli strains, the results were graphically represented as percent values from controls (the mean absorbance value in each plate of biofilm growth in the absence of CFS). Biofilm production was influenced by all Lactobacillus filtrates ( Figure 2) . Biofilm modulation varied from significant inhibition, though no statistically significant effect, to stimulation dependent on the combinations of E. coli strains and LB filtrates. In spite of the E. coli strain-to-strain differences, CFS from vaginal lactobacilli were more successful in suppressing E. coli sessile growth. The effects were more pronounced for E. coli K-12 strains than for clinical isolates. A similar trend characterized the spent media of two of the dairy-product lactobacilli, LB10 and LB11, and statistically significant biofilm reduction occurred in most strains of E. coli.
Biofilm-modulation activities of LB6 and LB7 are of particular interest. Even in non-inhibitory amounts, these two supernatants slowed down E. coli growth (see Figure 1 ). In the CV assay, LB6 unexpectedly increased biofilm production in three of the examined E. coli strains and had no effect on the other ones, and LB7 stimulated sessile growth in one and had no effect on three E. coli strains.
Biofilm suppression characteristics were most consistent in the presence of LB1, LB5 and LB10 CFS. When applied diluted 10 -2 , LB1 and LB5 inhibited more than 50% the biofilm growth of all the E. coli K-12 strains and the clinical isolate E. coli PU-3, and were also effective with the other two uropathogenic strains. LB10 suppressed more than 50% the biofilms of E. coli 420 and PU-3, and significantly, though less effectively, the other tested E. coli. These filtrates seem promising as sources of biofilm inhibitors. For this reason, their impact on biofilm structure was examined, and an attempt was made to identify the nature of the active biofilm-suppressive substance(s).
Effects of LB1, LB5 and LB10 on E. coli biofilm morphology
In scanning electron microscopy experiments, RR was applied in the fixatives to preserve the extracellular matrix during dehydration. Biofilm morphology in controls differed between strains. E. coli 420 produced a thick film with a rough surface and large cell patches protruding upwards. Sessile growth in the presence of LB1 and LB5 (10 -2 ) resulted in a sticky morphology with flattened cell patches and fracture-like spaces between them. LB10 had an apparently stronger deteriorating effect on this strain. All other strains formed flat sessile communities, and E. coli PU-1 is shown as a representative example of this biofilm morphotype.
CFS application resulted in uneven substratum coverage, with alternation between cell monolayers and more or less thicker films.
To check for the vitality of cells in the biofilms, the Live/Dead fluorescence stain test was applied. This is a combination of Syto 9
® which colors all cells green, and propidium iodide which penetrates dead cells only. The test showed no substantial differences between control and LB-treated samples regarding the amounts of dead cells (Figure 3) .
Figure 1. Growth of E. coli W1655 (A), E. coli 420 (B), E. coli 406 (C), E. coli PU-1 (D), E. coli PU-3 (E) and E. coli PU-13 (F) in minimal M63
medium supplemented with 10 -2 MRS (control) or 10 -2 CFS from LB5, LB6 and LB7 slowed down growth during early intervals. The other LB filtrates caused no notable differences from controls, and LB5 is included as a representative sample for them. Each time point represents the mean absorbance of 6 wells, error bars stand for standard deviations.
Influence of LB1, LB5 and LB10 on E. coli hydrophobicity and motility
One possible way by which the selected CFS could reduce biofilms is via changes in cell surface hydrophobicity, important especially during initial adherence to the hydrophobic surface of the polystyrene plates. When the E. coli strains were cultivated in M63 medium supplemented with 10 -2 of the three CFS, a general trend of hydrophobicity diminution was observed ( Table 2 ). The motility test was performed at 22°C in 0.3% agar in either M63 medium alone, or M63 supplemented with 10 -2 of LB1, LB5 or LB10. Motility halos developed 7 hours later around only two of the UPEC strains, with distinct reduction of the diameters measured in the cases of CFS supplementation ( Table 2) . Under the experimental conditions, all other strains were nonmotile. 
Contribution of polypeptides and rPS to biofilm modulating activities of LB1, LB5, and LB10
To check for a possible contribution of secreted proteins or peptides to the activities of the three CFS, proteinase K treatment was applied. Removal of proteins and/or polypeptides from the CFS resulted in higher biofilm growth than in enzymatically non-treated CFS (Figure 4 ). However, with some strain-to-strain differences, this treatment did not completely restore the values of the control biofilm. In addition, the possible role of extracellular rPs secreted during the Lactobacillus cultivation on E. coli sessile growth was estimated. With this aim, we first determined the rPS amounts in dyalised total CFS. The established values were 1200 μg/ml for LB1, 1700 μg/ml for LB5, and 800 μg/ml for LB10. We then checked the effect of 10 μg/ml (approximately -the rPS amount in 10 -2 dilution of the three total CFS) to biofilm growth. Unexpectedly, the samples had a biofilm-stimulating effect rather than an inhibitory affect on all E. coli strains except E. coli 420 ( Figure 5 ).
Discussion
The antibacterial activities of secreted metabolites from a variety of Lactobacillus strains against different pathotypes of E. coli have been well-documented [14] [15] [16] 21] . It has been shown that 80% CFS from L. rhamnosus GR-1 and L. reuteri RC-14 can influence surface membrane characteristics of an UPEC isolate by upregulation of OMPs and downregulation of type 1 and P fimbriae synthesis [17] . Furthermore, non-diluted CFS from L. rhamnosus GR-1 were able to influence pre-formed UPEC biofilms by increasing the number of dead cells and decreasing cell density [19] . Antibacterial activities of Lactobacillus non-diluted CFS may thus be a decisive factor for biofilm deterioration [19] .
Other organisms, e.g. Pseudomonas aeruginosa, Hafnia alveyi, and marine microorganisms such as Pseudoalteromonas sp and coral-associated actinomycetes, were shown to contain CFS component(s) which have biofilm-modulating activities per se, either stimulating or suppressing attached growth, and are not antimicrobial [30] [31] [32] [33] [34] . As a result of the increasing incidence of antibiotic-resistant strains, such results put into focus the search for substances that may be active in biofilm suppression without killing bacteria. Likely was the rationale of the present study, which was focused on the effects of highly diluted non-inhibitory amounts (10 -2 to 10 -4 ) of CFS from a novel collection of Lactobacillus strains on E. coli biofilm formation.
The examined CFS from 11 Lactobacillus strains were previously shown to have a broad spectrum of antibacterial activity against Gram positive and Gram negative reference strains and antibiotic-resistant outpatient strains, two Acinetobacter baumannii and two Pseudomonas aeruginosa. Based on these results, strains LB6 and LB7 were considered as probiotic candidate strains with strong transit tolerance and biological activity [22] [23] [24] . The present results are in support of this. Even when diluted 10 -2 , these two CFS, while not producing zones of inhibition on Mueller-Hinton agar, still slowed down the growth of the E. coli strains at early log phase (2-6 h) (Figure 1 ). This shows that antibacterial potential of the CFS does not necessarily predict an antibiofilm action.
The observed biofilm modulation by the CFS varied highly according to the combination of different CFS and E. coli strains. Similarly, a recent study on the effects of CFS from water-borne bacteria indicated variable outputs depending on strain-CFS combinations [35] .
The results on E. coli biofilm modulation by LB6 andLB7 filtrates are of particular interest. Unlike their suppressing effects on E. coli growth, these CFS stimulated sessile growth in some E. coli strains, including one of the UPEC (Figure 2) . Similarly, spent cultures of several probiotic bacterial species that had antibacterial activity against enteroaggregative E. coli stimulated instead of suppressing biofilm growth [21] . Such results indicate switching-on of protective mechanisms in E. coli and illustrate biofilm growth as an adaptation to unfavorable environmental clues.
Most consistent in their suppressive effects were LB1, LB5 and LB10. These were observed in most E. coli strains, not only with the 10 -2 , but also with 10 -3 and 10 -4 dilutions. The Live/Dead fluorescence test did not show a significant increase of dead E. coli cells in biofilms grown in the presence of the three CFS. Hence, the deteriorating effects of these CFS on biofilm growth involve mechanisms different from bactericidal action. The results imply that the biofilm modulation activities of the CFS are not necessarily correlated with their antibacterial potential, and that biofilm suppression was due to factors and mechanisms other than antibacterial activity. Thus, the presently observed reduction of surface hydrophobicity and suppression of motility show that 10 -2 dilutions of the three CFS can affect E. coli phenotypic characteristics important in the contacts with the substratum during the early stages of biofilm settlement.
To this moment, antibacterial activities of secreted metabolites from Lactobacillus strains have been attributed to several types of molecules: H 2 O 2 , lactic acid, biosurfactants, and antibacterial peptides [12] . Under our experimental conditions (use of frozen CFS samples at high dilutions), H 2 O 2 was unlikely to have any contribution. Since supplementation of M63 with 10 -2 to 10 -4 CFS did not change the pH of the medium, the impact of organic acids was also not probable.
Other candidate molecules could be released polysaccharides [36] and secreted proteins [37, 38] . Hence, we concentrated on the putative biofilm-modulation impact of released proteins and polysaccharides in LB1, LB5 and LB10. We demonstrated that proteolytic treatment reduced the biofilm-suppressive effects of LB1, LB5 and LB10 while 10 μg/ml of rPS from LB1, LB5 and LB10, an amount within the range in which rPS are present in these CFS under 10 -2 dilution, had a biofilm-stimulating effect on most E. coli strains. Such an output of the rPS application differs from existing results, showing that polysaccharides released in bacterial culture media reduced biofilm production [36, 39] . This could be due to differences in the rPS molecules, but is more likely due to the experimental protocol. Other authors included much higher quantities of rPS, while in this experimental protocol, it was applied in small amounts of the order in which it is present in the 10 -2 diluted CFS. Taken together, our results imply that the presently observed biofilm suppression by 10 -2 diluted LB1, LB5 and LB10 is, at least in part, due to peptide or protein factor(s). These probably antagonize the biofilm-promoting effects of the respective rPS.
In summary, the present results provided evidence that the examined set of Lactobacillus strains release into the culture medium substances with pronounced biofilm-modulating properties even at high-order dilutions (10 -2 to 10 -4 ). The observed effects were most probably due to mechanisms different from bactericidal action. The E. coli strains showed individual responses to each of the 11 LB supernatants, but LB1, LB and LB10 were biofilm-suppressive throughout, and hence are a promising source of biofilm-suppression factor(s). The variety of strain-specific E. coli responses to the treatments indicated a multifactorial interaction. This may concern both the composition of the different CFS and strain-peculiar mechanisms of biofilm production in the tested set of E. coli strains.
